Your browser doesn't support javascript.
loading
Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.
Huh, Warner K; Brady, William E; Fracasso, Paula M; Dizon, Don S; Powell, Matthew A; Monk, Bradley J; Leath, Charles A; Landrum, Lisa M; Tanner, Edward J; Crane, Erin K; Ueda, Stefanie; McHale, Michael T; Aghajanian, Carol.
Afiliação
  • Huh WK; University of Alabama at Birmingham, Division of Gynecologic Oncology, Birmingham, AL 35249, United States of America. Electronic address: whuh@uabmc.edu.
  • Brady WE; NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park, Buffalo, NY 14263, United States of America.
  • Fracasso PM; Department of Medicine, University of Virginia, UVA Cancer Center, Charlottesville, VA 22908, United States of America. Electronic address: fracasso@virginia.edu.
  • Dizon DS; Division of Hematology-Oncology, Lifespan Cancer Institute, Rhode Island Hospital, Department of Medicine, Alpert Medical School of Brown University, Providence, RI 02903, United States of America.
  • Powell MA; Washington University School of Medicine, Saint Louis, MO 63110, United States of America. Electronic address: mpowell@wustl.edu.
  • Monk BJ; Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph Hospital, Phoenix, AZ 85016, United States of America. Electronic address: Monk@usoncology.com.
  • Leath CA; University of Alabama at Birmingham, Division of Gynecologic Oncology, Birmingham, AL 35249, United States of America. Electronic address: cleath@uabmc.edu.
  • Landrum LM; Oklahoma University Health Science Center, OB/GYN, Oklahoma City, OK 73104, United States of America. Electronic address: lisa-landrum@ouhsc.edu.
  • Tanner EJ; Johns Hopkins Medical Institutions, Baltimore, MD 21287, United States of America. Electronic address: etanner4@jhmi.edu.
  • Crane EK; Department of Gynecologic Oncology, Carolinas Medical Center, Levine Cancer Institute, Charlotte, NC 28203, United States of America. Electronic address: erin.crane@atriumhealth.org.
  • Ueda S; University of California, San Francisco, OB/GYN & Reproductive Sciences, Division of Gyn Onc., San Francisco, CA 94115, United States of America. Electronic address: UedaS2@obgyn.ucsf.edu.
  • McHale MT; Moores UCSD Cancer Center, La Jolla, CA 92093, United States of America. Electronic address: mtmchale@ucsd.edu.
  • Aghajanian C; Memorial Sloan-Kettering Cancer Center, Dept. of Medical Oncology, New York, NY 10021, United States of America. Electronic address: aghajanc@mskcc.org.
Gynecol Oncol ; 158(3): 562-569, 2020 09.
Article em En | MEDLINE | ID: mdl-32641240
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Vacinas Anticâncer / Proteínas E7 de Papillomavirus / Listeria monocytogenes Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Vacinas Anticâncer / Proteínas E7 de Papillomavirus / Listeria monocytogenes Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article